These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26982250)

  • 1. Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.
    Czapar AE; Zheng YR; Riddell IA; Shukla S; Awuah SG; Lippard SJ; Steinmetz NF
    ACS Nano; 2016 Apr; 10(4):4119-26. PubMed ID: 26982250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Speciation of Phenanthriplatin and Its Analogs in the Core of Tobacco Mosaic Virus.
    Vernekar AA; Berger G; Czapar AE; Veliz FA; Wang DI; Steinmetz NF; Lippard SJ
    J Am Chem Soc; 2018 Mar; 140(12):4279-4287. PubMed ID: 29553267
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phenanthriplatin, a monofunctional DNA-binding platinum anticancer drug candidate with unusual potency and cellular activity profile.
    Park GY; Wilson JJ; Song Y; Lippard SJ
    Proc Natl Acad Sci U S A; 2012 Jul; 109(30):11987-92. PubMed ID: 22773807
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tobacco mosaic virus delivery of mitoxantrone for cancer therapy.
    Lin RD; Steinmetz NF
    Nanoscale; 2018 Aug; 10(34):16307-16313. PubMed ID: 30129956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tobacco Mosaic Virus-Delivered Cisplatin Restores Efficacy in Platinum-Resistant Ovarian Cancer Cells.
    Franke CE; Czapar AE; Patel RB; Steinmetz NF
    Mol Pharm; 2018 Aug; 15(8):2922-2931. PubMed ID: 28926265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Delivery of Cationic Platinum Prodrugs via Reduction Sensitive Polymer for Improved Chemotherapy.
    Chen H; Wang Y; Liu Y; Tang L; Mu Q; Yin X; Zheng L; Chen Y; Liu C
    Small; 2021 Nov; 17(45):e2101804. PubMed ID: 34554644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cisplatin-Loaded Tobacco Mosaic Virus for Ovarian Cancer Treatment.
    Zhao Z; Simms A; Steinmetz NF
    Biomacromolecules; 2022 Oct; 23(10):4379-4387. PubMed ID: 36053908
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The chiral potential of phenanthriplatin and its influence on guanine binding.
    Johnstone TC; Lippard SJ
    J Am Chem Soc; 2014 Feb; 136(5):2126-34. PubMed ID: 24417436
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of a monofunctional phenanthriplatin-DNA adduct on RNA polymerase II transcriptional fidelity and translesion synthesis.
    Kellinger MW; Park GY; Chong J; Lippard SJ; Wang D
    J Am Chem Soc; 2013 Sep; 135(35):13054-61. PubMed ID: 23927577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural and mechanistic studies of polymerase η bypass of phenanthriplatin DNA damage.
    Gregory MT; Park GY; Johnstone TC; Lee YS; Yang W; Lippard SJ
    Proc Natl Acad Sci U S A; 2014 Jun; 111(25):9133-8. PubMed ID: 24927576
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
    Kernan DL; Wen AM; Pitek AS; Steinmetz NF
    Exp Biol Med (Maywood); 2017 Aug; 242(14):1405-1411. PubMed ID: 28675044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA-Seq Analysis of Cisplatin and the Monofunctional Platinum(II) Complex, Phenanthriplatin, in A549 Non-Small Cell Lung Cancer and IMR90 Lung Fibroblast Cell Lines.
    Monroe JD; Moolani SA; Irihamye EN; Speed JS; Gibert Y; Smith ME
    Cells; 2020 Dec; 9(12):. PubMed ID: 33302475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phenanthriplatin Acts As a Covalent Poison of Topoisomerase II Cleavage Complexes.
    Riddell IA; Agama K; Park GY; Pommier Y; Lippard SJ
    ACS Chem Biol; 2016 Nov; 11(11):2996-3001. PubMed ID: 27648475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DNA Intercalation Facilitates Efficient DNA-Targeted Covalent Binding of Phenanthriplatin.
    Almaqwashi AA; Zhou W; Naufer MN; Riddell IA; Yilmaz ÖH; Lippard SJ; Williams MC
    J Am Chem Soc; 2019 Jan; 141(4):1537-1545. PubMed ID: 30599508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
    Pitek AS; Hu H; Shukla S; Steinmetz NF
    ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Understanding and improving platinum anticancer drugs--phenanthriplatin.
    Johnstone TC; Park GY; Lippard SJ
    Anticancer Res; 2014 Jan; 34(1):471-6. PubMed ID: 24403503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nucleotide Binding Preference of the Monofunctional Platinum Anticancer-Agent Phenanthriplatin.
    Riddell IA; Johnstone TC; Park GY; Lippard SJ
    Chemistry; 2016 May; 22(22):7574-81. PubMed ID: 27111128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monofunctional platinum(II) compounds and nucleolar stress: is phenanthriplatin unique?
    McDevitt CE; Yglesias MV; Mroz AM; Sutton EC; Yang MC; Hendon CH; DeRose VJ
    J Biol Inorg Chem; 2019 Sep; 24(6):899-908. PubMed ID: 31494760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tobacco mosaic virus-based protein nanoparticles and nanorods for chemotherapy delivery targeting breast cancer.
    Bruckman MA; Czapar AE; VanMeter A; Randolph LN; Steinmetz NF
    J Control Release; 2016 Jun; 231():103-13. PubMed ID: 26941034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is the cytotoxic activity of phenanthriplatin dependent on the specific size of the phenanthridine ligand π system?
    Scoditti S; Dabbish E; Sicilia E
    J Inorg Biochem; 2021 Jun; 219():111447. PubMed ID: 33798829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.